Asker Healthcare Group revenue and financials

ASKER · Nasdaq Stockholm · SEK

kr 66.30Change from previous close: −0.60%Absolute change: −kr 0.40

Close · October 7, 2026

In the fiscal year ended December 2025, Asker Healthcare Group reported revenue of kr 16.79B (+11.73% year over year). Net income was kr 492M, a net margin of 2.9%.

Annual revenue · 2025: kr 16.79B
  1. kr 11.72B2022
  2. kr 13.45B2023
  3. kr 15.03B2024
  4. kr 16.79B2025

Fiscal year ending in December. Sources and method on the page Methodology and sources.

At a glance

Revenue growth
+11.73%
2025 vs 2024
Net income growth
+36.67%
2025 vs 2024
Net margin
2.9%
2024: 2.4%

Financial data

Amounts in millions of SEK; per-share values in SEK; shares in millions.

Balance sheet · Quarterly
ItemQ2 2026Q1 2026Q4 2025Q2 2025Q1 2025
Total assets17,83217,75316,77415,20814,234
Current assets5,7945,8535,4725,5984,859
Cash and equivalents7779458841,325735
Inventory2,3642,1832,0411,9381,880
Net property, plant and equipment1,8771,8881,7791,4741,435
Goodwill6,7586,6356,3695,6515,553
Other intangible assets3,2743,2303,0262,3742,278
Long-term investments——0.0——
Current liabilities4,4394,4774,0373,9012,802
Accounts payable1,6721,6981,6101,3481,363
Long-term debt4,2564,2424,2243,3613,321
Total debt6,4766,0185,8145,1084,240
Total liabilities10,81310,88210,1868,7847,996
Total equity (incl. minority)7,0196,8716,5886,4246,238
Retained earnings——2,145——
Minority interest41.038.033.038.032.0